Study of Subcutaneous Immunoglobulin in Patients With PID Requiring IgG Replacement Therapy

Clinical trial NCT00419341 · COMPLETED

Trial details

NCT number: NCT00419341
Sponsor: CSL Behring
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Immune Deficiency

Start date: 2006-11-01
Primary completion: 2008-10-01
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.